Obese individuals are more likely to develop heart failure. Yet, once heart failure is established, the impact of overweight and obesity on prognosis and survival is unclear. The purpose of this joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension is to provide an overview on the current scientific literature on obesity and heart failure in terms of prognosis, mechanisms, and clinical management implications. Moreover, the document identifies open questions that ought to be addressed. The need for more tailored weight management recommendations in heart failure will be emphasized and, in line with the emerging evidence, aims to distinguish between primary disease and secondary outcome prevention. In the primary prevention of heart failure, it appears prudent advising obese individuals to lose or achieve a healthy body weight, especially in those with risk factors such as hypertension or type 2 diabetes. However, there is no evidence from clinical trials to guide weight management in overweight or obese patients with established heart failure. Prospective clinical trials are strongly encouraged.

Jordan, J., Toplak, H., Grassi, G., Yumuk, V., Kotsis, V., Engeli, S., et al. (2016). Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and heart failure. JOURNAL OF HYPERTENSION, 34(9), 1678-1688 [10.1097/HJH.0000000000001013].

Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and heart failure

Grassi, G;Cuspidi, C;
2016

Abstract

Obese individuals are more likely to develop heart failure. Yet, once heart failure is established, the impact of overweight and obesity on prognosis and survival is unclear. The purpose of this joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension is to provide an overview on the current scientific literature on obesity and heart failure in terms of prognosis, mechanisms, and clinical management implications. Moreover, the document identifies open questions that ought to be addressed. The need for more tailored weight management recommendations in heart failure will be emphasized and, in line with the emerging evidence, aims to distinguish between primary disease and secondary outcome prevention. In the primary prevention of heart failure, it appears prudent advising obese individuals to lose or achieve a healthy body weight, especially in those with risk factors such as hypertension or type 2 diabetes. However, there is no evidence from clinical trials to guide weight management in overweight or obese patients with established heart failure. Prospective clinical trials are strongly encouraged.
Articolo in rivista - Articolo scientifico
heart failure; hypertension; neurohumoral; obesity; obesity paradox;
heart failure, hypertension, neurohumoral, obesity, obesity paradox
English
2016
34
9
1678
1688
none
Jordan, J., Toplak, H., Grassi, G., Yumuk, V., Kotsis, V., Engeli, S., et al. (2016). Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and heart failure. JOURNAL OF HYPERTENSION, 34(9), 1678-1688 [10.1097/HJH.0000000000001013].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/128749
Citazioni
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
Social impact